Potency preservation following conformal radiotherapy for localized prostate cancer: Impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors

Cancer Journal from Scientific American

Volumn 5, Issue 4, 1999, Pages 230-236

  Mantz, C A ^a   Nautiyal, J ^a   Awan, A ^a   Kopnick, M ^b   Ray, P ^c   Kandel, G ^b   Niederberger, C ^b   Ignacio, L ^a   Dawson, E ^a   Fields, R ^a   Weichselbaum, R ^a   Vijayakumar, Srinivasan ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b MICHAEL REESE HOSPITAL   (United States)

^c Jr Hospital of Cook County   (United States)

Author keywords

Conformal radiotherapy; Impotence; Prostate cancer; Prostatectomy; Quality of life

Indexed keywords

FLUTAMIDE; LEUPRORELIN;

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; DRUG POTENCY; HORMONE INHIBITION; HUMAN; IMPOTENCE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANDROGEN ANTAGONISTS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES;

EID: 0032756216     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bagshaw MA, Cox RS, Ray GR. Status of radiation treatment of prostate cancer at Stanford University. Natl Cancer Inst Monog 1988;7:47-60.
2. Banker FL. The preservation of potency after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 1988;15: 219-220.
3. Loh ES, Brown EH, Beiler DD. Radiotherapy of carcinoma of the prostate: preliminary report. J Urol 1971;108:906-909.
4. Mantz CA, Song P, Farhangi E et al. Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer. Int J Radiat Oncol Biol Phys 1997; 37:551-557.
5. Mollenkamp JS, Cooper FJ, Kagan AR. Clinical experience with supervoltage radiotherapy in carcinoma of the prostate. A preliminary report. J Urol 1975;113:374-377.
6. Perez CA, Bauer W, Garza R et al. Radiation therapy in the definitive treatment of localized carcinoma of the prostate. Cancer 1977; 40:1425-1433.
7. Ray GR, Cassady JR, Bagshaw MA. Definitive radiation therapy of carcinoma of the prostate: a report on 15 years of experience. Radiology 1973;106:407-418.
8. Schelhammer PF, El-Mahdi AM. Pelvic complications after definitive treatment of prostate cancer by interstitial or external beam radiation. Urology 1983;21:451-457.
9. Shipley WU, Prout GR Jr, Coachman NM et al. Radiation therapy for localized prostate carcinoma: experience at the Massachusetts General Hospital 1973-1981. Natl Cancer Inst Monogr 1988;7:67-73.
10. Correa RJ, Jr, Gibbons RP, Cummings KB et al. Total prostatectomy for stage B carcinoma of the prostate. J Urol 1977;117:328-329.
11. Gibbons RP, Correa RJ, Brannen GE et al. Total prostatectomy for localized prostate cancer. J Urol 1984;131:73.
12. Jewett HJ, Bridge RW, Gray GF et al. The palpable nodule of prostate cancer: results 15 years after excision. JAMA 1968;203: 403-406.
13. Kopecky AA, Laskowski TZ, Scott R Jr. Radical retropubic prostatectomy in the treatment of prostate carcinoma. J Urol 1970; 103:641.
14. Veenema RJ, Gursel EO, Lattimer JK. Radical retropubic prostatectomy for cancer: a 20-year experience. J Urol 1977;117:330.
15. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982;128:492.
16. Walsh PC. Radical prostatectomy, preservation of sexual function, cancer control: the controversy. Urol Clin North Am 1987;14: 663-673.
17. Walsh PC. Radical retropubic prostatectomy. In: Walsh PC, Gittes RF, Perlmutter AD et al, eds. Campbell's Urology (5th ed). Philadelphia: WB Saunders 1986:2754-2775.
18. Walsh PC, Epstein JI, Lowe FC. Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle. J Urol 1987;138:823.
19. Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 1983;4:473.
20. Catalona WJ, Bigg SW. Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol 1990;143:538-544.
21. Eggleston JC, Walsh PC. Radical prostatectomy with preservation of sexual function: pathologic findings in the first 100 cases. J Urol 1985;134:1146.
22. Geary ES, Dendinger TE, Freiha FS et al. Nerve-sparing radical prostatectomy. J Urol 1995;154:145-149.
23. Quinlan DM, Epstein JI, Carter BS et al. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991;145:998-1002.
24. Low NN, Vijayakumar S, Rosenberg I et al. Beam's eye view based prostate treatment planning: is it useful? Int J Radiat Oncol Biol Phys 1990;19:759-768.
25. Soffen EM, Hanks GE, Hwang CC et al. Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. Int J Radiat Oncol Biol Phys 1991;20:141-146.
26. Vijayakumar S, Awan A, Karrison T et al. Acute toxicity during external-beam radiotherapy for localized prostate cancer: comparison of different techniques. Int J Radiat Oncol Biol Phys 1993;25: 359-371.
27. Vijayakumar S, Low N, Chen GTY et al. Beam's eye view based photon radiotherapy I. Int J Radiat Oncol Biol Phys 1991;21: 1575-1586.
28. Cutler S, Ederer F. Maximum utilization of the lifetable method in analyzing survival. J Chronic Dis 1958;8:699-712.
29. Jonler M, Messing EM, Rhodes PR et al. Sequelae of radical prostatectomy. Br J Urol 1994;74:352-358.
30. Leandri P, Rossignol G, Gautier J-R et al. Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol 1992;147:883-887.
31. Walsh PC. Radical retropubic prostatectomy for early stage prostate cancer. Semin Oncol 1988;15:351-358.
32. Bagshaw MA. Organ and function preservation after x-irradiation for prostate cancer. Natl Cancer Inst Monogr 1991;10:257-268.
33. Jonler M, Messing EM, Ritter MA et al. Sequelae of definitive radiation therapy for prostate cancer localized to the pelvis. Urol 1994;44:876-882.
34. Leibel SA, Heimann R, Kutcher GJ et al. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study. Int J Radiat Oncol Biol Phys 1993;28:55-65.
35. Roach M, Chinn DM, Holland J et al. A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1996;35:869-874.
36. Soffen EM, Hanks GE, Hunt MA et al. Conformal static field radiation therapy treatment of early prostate cancer vs. nonconformal techniques: a reduction in acute morbidity. Im J Radiat Oncol Biol Phys 1992;24:485-488.
37. Van Heeringen C, De Schryver A, Verbeek E. Sexual function disorders after local radiotherapy for carcinoma of the prostate. Radiother Oncol 1988;13:47-52.
38. Zinreich ES, Derogati LR, Herpst J et al. Pre-and posttreatment evaluation of sexual function in patients with adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1990;19:729-732.
39. Pilepich MV, Krall JM, al-Sarraf M et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 1995; 45:616-623.
40. Anderson S. Statistical Methods for Comparative Studies. Philadelphia: WB Saunders, 1980.
41. Vijayakumar S, Myrianthopoulos LC, Dabrowski J et al. In the radiotherapy of prostate cancer, technique determines the doses to the penile structures. Br J Radiol 1999; in press.
42. Alexander RB, Maguire MG, Epstein JI et al. Pathologic stage is higher in older men with clinical stage B1 adenocarcinoma of the prostate. J Urol 1989;141:880.
43. Arai Y, Okada Y, Okada K et al. Clinical experience with nerve-sparing prostatectomy. Hinyokika Kiyo 1988;34:1403.
44. Goldstein I, Feldman MI, Deckers PJ et al. Radiation-associated impotence: a clinical study of its mechanism. JAMA 1984;251: 903-910.
45. Krane RJ, Goldstein I, de Tejada IS. Impotence. N Engl J Med 1989;321:1648-1659.
46. Ruzbarsky V, Michel V. Morphologic changes in the arterial bed of the penis with aging: relationship to the pathogenesis of impotence. Invest Urol 1977;15:194-199.
47. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? a study of arterial risk factors in 440 impotent men. Lancet 1985; 1:181-184.
48. Padma-Nathan H, Hellstrom WJG, Kaiser F et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med 1997;336:1-7.